Viewing Study NCT00819104


Ignite Creation Date: 2025-12-24 @ 9:18 PM
Ignite Modification Date: 2026-05-17 @ 12:39 PM
Study NCT ID: NCT00819104
Status: COMPLETED
Last Update Posted: 2009-09-09
First Post: 2009-01-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual Components
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Primary Hypertension View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Primary hypertension View
None Metoprolol XL View
None Amlodipine View